CS208164B2 - Method of making the d-2-halogene-6-methyl-8-kyan/carboxamido/methylergolines - Google Patents

Method of making the d-2-halogene-6-methyl-8-kyan/carboxamido/methylergolines Download PDF

Info

Publication number
CS208164B2
CS208164B2 CS735239A CS523973A CS208164B2 CS 208164 B2 CS208164 B2 CS 208164B2 CS 735239 A CS735239 A CS 735239A CS 523973 A CS523973 A CS 523973A CS 208164 B2 CS208164 B2 CS 208164B2
Authority
CS
Czechoslovakia
Prior art keywords
methyl
ergoline
formula
compounds
compound
Prior art date
Application number
CS735239A
Other languages
Czech (cs)
English (en)
Inventor
James A Clemens
Edmund C Kornfeld
Nicholas J Bach
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to CS776672A priority Critical patent/CS208165B2/cs
Publication of CS208164B2 publication Critical patent/CS208164B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS735239A 1972-07-21 1973-07-20 Method of making the d-2-halogene-6-methyl-8-kyan/carboxamido/methylergolines CS208164B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS776672A CS208165B2 (cs) 1972-07-21 1977-10-13 Způsob výroby D-6-methyl-8-mesyIoxymethylergoIinu

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27390272A 1972-07-21 1972-07-21

Publications (1)

Publication Number Publication Date
CS208164B2 true CS208164B2 (en) 1981-08-31

Family

ID=23045910

Family Applications (1)

Application Number Title Priority Date Filing Date
CS735239A CS208164B2 (en) 1972-07-21 1973-07-20 Method of making the d-2-halogene-6-methyl-8-kyan/carboxamido/methylergolines

Country Status (24)

Country Link
JP (2) JPS576431B2 (US20050192411A1-20050901-C00001.png)
AR (3) AR206772A1 (US20050192411A1-20050901-C00001.png)
AT (1) AT331425B (US20050192411A1-20050901-C00001.png)
BE (1) BE802531A (US20050192411A1-20050901-C00001.png)
BG (3) BG21410A3 (US20050192411A1-20050901-C00001.png)
CA (1) CA1006159A (US20050192411A1-20050901-C00001.png)
CH (5) CH581135A5 (US20050192411A1-20050901-C00001.png)
CS (1) CS208164B2 (US20050192411A1-20050901-C00001.png)
DD (1) DD107690A5 (US20050192411A1-20050901-C00001.png)
DE (2) DE2335750C3 (US20050192411A1-20050901-C00001.png)
DK (1) DK140986B (US20050192411A1-20050901-C00001.png)
ES (5) ES417078A1 (US20050192411A1-20050901-C00001.png)
FR (1) FR2193606B1 (US20050192411A1-20050901-C00001.png)
GB (1) GB1423065A (US20050192411A1-20050901-C00001.png)
HU (1) HU167274B (US20050192411A1-20050901-C00001.png)
IE (1) IE37936B1 (US20050192411A1-20050901-C00001.png)
IL (3) IL42730A (US20050192411A1-20050901-C00001.png)
NL (1) NL7309969A (US20050192411A1-20050901-C00001.png)
PH (1) PH11229A (US20050192411A1-20050901-C00001.png)
RO (2) RO63792A (US20050192411A1-20050901-C00001.png)
SE (3) SE393111B (US20050192411A1-20050901-C00001.png)
SU (3) SU645581A3 (US20050192411A1-20050901-C00001.png)
YU (1) YU36953B (US20050192411A1-20050901-C00001.png)
ZA (1) ZA734627B (US20050192411A1-20050901-C00001.png)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1517973A (en) * 1974-07-19 1978-07-19 Sandoz Ltd 6-methyl-8alpha-n,n-dimethylsulphamoylaminoergoline i
US3968111A (en) * 1974-12-06 1976-07-06 Eli Lilly And Company 8,8-Disubstituted-6-methylergolines and related compounds
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
AU526764B2 (en) * 1978-09-08 1983-01-27 Farmitalia Carlo Erba S.P.A. Ergoline derivatives
DE3587860D1 (de) * 1984-04-09 1994-07-28 Schering Ag 2-substituierte Ergolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
HU196598B (en) * 1986-04-25 1988-12-28 Richter Gedeon Vegyeszet Process for producing 1- and/or 8-substituted 2-halogenated ergoline derivatives and pharmaceutics comprising such compounds
DE3620293A1 (de) * 1986-06-16 1987-12-17 Schering Ag 1-und/oder 2-substituierte ergolinderivate
JPH0596382U (ja) * 1992-05-28 1993-12-27 イビデン株式会社 ドアユニット

Also Published As

Publication number Publication date
ZA734627B (en) 1974-06-26
PH11229A (en) 1977-10-28
CH580626A5 (US20050192411A1-20050901-C00001.png) 1976-10-15
CH578564A5 (US20050192411A1-20050901-C00001.png) 1976-08-13
SE410459B (sv) 1979-10-15
DK140986B (da) 1979-12-17
BG21411A3 (US20050192411A1-20050901-C00001.png) 1976-05-20
BG21410A3 (bg) 1976-05-20
AR210072A1 (es) 1977-06-30
GB1423065A (en) 1976-01-28
YU194573A (en) 1982-06-18
ES446789A1 (es) 1977-06-01
NL7309969A (US20050192411A1-20050901-C00001.png) 1974-01-23
IL42730A0 (en) 1973-10-25
ES442887A1 (es) 1977-05-16
AU5792673A (en) 1975-01-16
IL42730A (en) 1976-06-30
CH581135A5 (US20050192411A1-20050901-C00001.png) 1976-10-29
ES442885A1 (es) 1977-04-16
IL48288A0 (en) 1975-12-31
CH578563A5 (US20050192411A1-20050901-C00001.png) 1976-08-13
DE2335750B2 (de) 1978-02-23
DE2365974A1 (de) 1977-03-24
JPS4985099A (US20050192411A1-20050901-C00001.png) 1974-08-15
RO71305A (ro) 1982-03-24
SE410603B (sv) 1979-10-22
DD107690A5 (US20050192411A1-20050901-C00001.png) 1974-08-12
IL48288A (en) 1976-06-30
IE37936L (en) 1974-01-21
SE393111B (sv) 1977-05-02
JPS576431B2 (US20050192411A1-20050901-C00001.png) 1982-02-04
SU584780A3 (ru) 1977-12-15
FR2193606A1 (US20050192411A1-20050901-C00001.png) 1974-02-22
FR2193606B1 (US20050192411A1-20050901-C00001.png) 1977-07-15
SU575029A3 (ru) 1977-09-30
JPS5781487A (en) 1982-05-21
SU645581A3 (ru) 1979-01-30
DK140986C (US20050192411A1-20050901-C00001.png) 1980-07-21
SE7611467L (sv) 1976-10-15
HU167274B (US20050192411A1-20050901-C00001.png) 1975-09-27
ES442886A1 (es) 1977-04-16
IE37936B1 (en) 1977-11-23
DE2335750C3 (de) 1978-10-19
ES417078A1 (es) 1976-05-01
AR206772A1 (es) 1976-08-23
BG22400A3 (bg) 1977-02-20
BE802531A (fr) 1974-01-21
CH580625A5 (US20050192411A1-20050901-C00001.png) 1976-10-15
AT331425B (de) 1976-08-25
AR206887A1 (es) 1976-08-31
ATA643473A (de) 1975-11-15
SE7611466L (sv) 1976-10-15
JPS5813541B2 (ja) 1983-03-14
CA1006159A (en) 1977-03-01
DE2335750A1 (de) 1974-02-14
RO63792A (fr) 1978-12-15
YU36953B (en) 1984-08-31

Similar Documents

Publication Publication Date Title
US3920664A (en) D-2-halo-6-alkyl-8-substituted ergolines and related compounds
US4054660A (en) Method of inhibiting prolactin
JPS6049192B2 (ja) 新規置換ベンズアミド、その製造方法及びこれを有効成分とする向精神薬
CS199591B2 (en) Process for preparing 8-thimethylergolines
EP0026671A1 (en) Novel ergoline derivatives, compositions containing them, their preparation and use as pharmaceuticals
JP2000511186A (ja) ゴナドトロピン放出ホルモン拮抗薬
US3962258A (en) 1,2,3,4,6,7,12,12B-Octahydro-2-benzamidoindolo[2,3-a]quinolizine
CS208164B2 (en) Method of making the d-2-halogene-6-methyl-8-kyan/carboxamido/methylergolines
JPS6030677B2 (ja) 新規な6−フェニル−4H−イミダゾ〔1,2−α〕〔1,4〕ベンゾジアゼピン類の製造方法
US3238211A (en) Derhvatives of g-methyl and i,g-dimethyl ergolhne
CS199610B2 (en) Process for preparing 8-8-disubstituted 6-methylergolines and derivatives thereof
FI59254C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara ergopeptinderivat
EP0174858A1 (en) Isoindolinone derivatives, production and use thereof
US3228944A (en) Lumiergoline derivatives
AU598510B2 (en) Pyrrolo (1,2-a)(4,1) benzoxazepine derivatives
CS200483B2 (en) Process for preparing 6-methyl-8-/2-methylsulphinylethyl/ergoline
US4707484A (en) Substituted piperidinomethylindolone and cyclopent(b)indolone derivatives
CZ410691A3 (en) N-(2-methoxyethyl)-noroxymerphone, process of its preparation and pharmaceutical compositions containing it
JPH0210834B2 (US20050192411A1-20050901-C00001.png)
JPH0513955B2 (US20050192411A1-20050901-C00001.png)
IE51341B1 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them
KR800000413B1 (ko) 6-메틸-8-(치환)메틸 에르골린류의 제조방법
CS236782B2 (en) Processing of 5 s-(2r-butyl)peptidergotalkaloid
KR800000414B1 (ko) 6-메티-8-(치환)메틸에르골린류의 제조방법
EP0411495A2 (en) Ergoline derivatives of proline and related compounds having dopaminergic activity